Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-18

FDA Approved: BETAMETHASONE VALERATE — Original Application (Xiromed, LLC.)

View source ↗

Summary

FDA approved Xiromed, LLC's Betamethasone Valerate Foam as an original ANDA, establishing a generic version of betamethasone valerate foam for topical use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Betamethasone Valerate Foam (Betamethasone valerate)

Snippet

ORIG AP for BETAMETHASONE VALERATE (BETAMETHASONE VALERATE FOAM)